Your browser doesn't support javascript.
loading
Combination use of medicines from two classes of renin-angiotensin system blocking agents: risk of hyperkalemia, hypotension, and impaired renal function.
Esteras, Raquel; Perez-Gomez, Maria Vanessa; Rodriguez-Osorio, Laura; Ortiz, Alberto; Fernandez-Fernandez, Beatriz.
Affiliation
  • Esteras R; IIS-Fundacion Jimenez Diaz, School of Medicine, Universidad Autónoma de Madrid and Fundacion Renal Iñigo Alvarez de Toledo-IRSIN, and REDINREN, Madrid, Spain.
  • Perez-Gomez MV; IIS-Fundacion Jimenez Diaz, School of Medicine, Universidad Autónoma de Madrid, and Fundacion Renal Iñigo Alvarez de Toledo-IRSIN, and REDINREN, Madrid, Spain.
  • Rodriguez-Osorio L; IIS-Fundacion Jimenez Diaz, School of Medicine, Universidad Autónoma de Madrid, and Fundacion Renal Iñigo Alvarez de Toledo-IRSIN, and REDINREN, Madrid, Spain.
  • Ortiz A; IIS-Fundacion Jimenez Diaz, School of Medicine, Universidad Autónoma de Madrid, and Fundacion Renal Iñigo Alvarez de Toledo-IRSIN, and REDINREN, Madrid, Spain.
  • Fernandez-Fernandez B; Department of Nephrology, Fundación Jiménez Díaz, Av Reyes Católicos 2, 28040 Madrid, Spain.
Ther Adv Drug Saf ; 6(4): 166-76, 2015 Aug.
Article in En | MEDLINE | ID: mdl-26301070
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Ther Adv Drug Saf Year: 2015 Document type: Article Affiliation country: Spain Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Etiology_studies / Risk_factors_studies Language: En Journal: Ther Adv Drug Saf Year: 2015 Document type: Article Affiliation country: Spain Country of publication: United kingdom